版本:
中国

BRIEF-Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101

Nov 28 Foamix Pharmaceuticals Ltd -

* Foamix announces completion of patient enrollment in phase 3 acne trials for Minocycline Foam FMX101

* Foamix Pharmaceuticals is conducting two phase 3 pivotal trials simultaneously, and expects to report top-line results in first half of 2017 Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐